Injection Therapy for Neuropathic Pain

• Status: Recruiting
• Trial end date: 2023-06-20
• Target enrollment: 0
• Participant gender: All

Summary

Shoulder, neck, back and temporal pain and herpes zoster pain are neuropathic pain. Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can relieve neuropathic pain. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dove Medical Press Ltd
• Collaborator: The Affiliated Hospital of Qingdao University
• Treatments: Hyaluronic Acid

Criteria

Inclusion Criteria:

• The course of neck, back and temporal pain ranged from 0 to 8 months.

• The course of herpes zoster of 0-2 months.

• Adults aged 18-60 years.

• Be willing and capable of giving informed consent.

• Have a clinical diagnosis of neuropathic pain as determined by a multidisciplinary study team.

• Subject must sign the informed consent in person prior to beginning any screening procedure.

Exclusion Criteria:

• Have a persistent pain resulted from other medical conditions or unknown causes.

• Pregnant females.

• Be concomitantly participating in another clinical study.

• Have been immunocompromised.